These outcomes are encouraging for pregnant women having type 2 diabetes, but it is not yet clear whether metformin treatment should be recommended for use by these women. Randomized trials will be needed to make this determination.doi:10.1097/01.ogx.0000228711.11397.2fHughes, R C. E....
The management of diabetes in the pregnant woman has important ramifications for the well-being of the mother and the fetus. Most women with diabetes can now safely undertake pregnancy. In recent years advances in medical and obstetric care have greatly improved the outlook for women with diabetes...
Objective: To test the hypothesis that, in women with type 1 diabetes, prenatal smoking and caffeine consumption during pregnancy are associated with an increased risk of adverse maternal and perinatal outcomes.Methods: A secondary analysis of data on pregnant women with type 1 diabetes from an ...
Findings In this cohort study of 7553 women with breast cancer, the 5-year overall survival was 87.5% for women with no pregnancy, 82.1% for women with pregnancy-associated breast cancer, and 96.7% for women who had pregnancy 6 months or more after diagnosis of breast cancer. The difference...
outcomes in these vulnerable populations. In this issue ofJAMAand in an issue ofJAMApublished in October 2023, 2 trials investigate the role of metformin during pregnancy to improve adverse outcomes: one trial in women with gestational diabetes and one trial in those with type 2 diabetes....
Nearly 90% of women with diabetes develop the condition during pregnancy; diabetes in the other 10% antedated the pregnancy. Since the discovery of insulin, perinatal mortality rates for women with diabetes have decreased, however, infant morbidity remains higher than in the nondiabetes pregnant ...
For decades, it is generally known that pregnant women with diabetes face a higher risk than non-diabetic women of giving birth to a baby with a congenital heart defect. The latest study established the correlation of higher sugar levels with the risks of heart defects in babies of non-diabet...
Moreover, after adjusting for confounding factors the risk of GMD significantly increased by tenfold in women with AMA in the universal TCP period. It is obvious that an increase in maternal age results in a higher incidence of GDM. In our findings, the proportion of GDM in women with AMA...
摘要: We examined the cumulative impact of interventions in pregnant women with pre-gestational diabetes, including guidelines, pre-pregnancy care, an app, and a web site. We recorded decrease in HbA1C, congenital malformations, and stillbirths....
Of the 298 pregnancies, 252 were associated with biologic exposure before or during pregnancy. Pregnancy outcomes for women exposed to biologics were similar to those for women exposed to nonbiologics. Among women who became pregnant, mean (SD) age at the time of pregnancy outcome was 30.9 (...